title: Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026?
source: Yahoo
date: 2025-10-15
url: https://finnhub.io/api/news?id=409ba5d4121d92f6d3772f0ec92f61fedacde3869d06d36700bb4a7de0512d26
Big Pharma reignites dealmaking as Pfizer, Novo Nordisk and Roche target obesity and metabolic diseases in a high-stakes 2025 M&A surge.
